Brca1 heterozygosity leads to hepatic steatosis in male and female mice despite sexually dimorphic effects on systemic metabolism
Sailesh PalikheiD, Linlan Qiao, Caleb Kutz, Xiaobo Liang, Poojaben DhorajiyaiD, Devin C. KoestleriD, Priya Bhardwaj, Colin S. McCoiniD, Aditi BarnwaliD, Orion J. PetersoniD, Hubert Ming TseiD, John P. ThyfaultiD, Kristy A. BrowniD
Abstract
Carrying a germline mutation in BRCA1 is associated with an increased risk of several cancers, including breast and ovarian. Our recent work has demonstrated that obesity is associated with elevated levels of DNA damage in breast glands in this high-risk population. BRCA1 is a canonical tumor suppressor gene primarily recognized for its role in DNA damage repair, yet emerging evidence suggests broader functions in metabolic regulation. To determine whether heterozygous loss of Brca1, as seen in individuals who carry a germline mutation, modifies susceptibility to diet-induced metabolic dysfunction in a sex-dependent manner, we subjected wild-type (WT) and Brca1+/- mice of both sexes to a high-fat diet (HFD) and performed longitudinal metabolic phenotyping. Female Brca1+/- mice exhibited pronounced obesity, increased adiposity, hyperinsulinemia, and impaired glucose tolerance. In contrast, male Brca1+/- mice showed modest resistance to HFD-induced weight gain and displayed improved glucose tolerance compared to WT controls. Notably, Brca1 heterozygosity led to more severe hepatic steatosis with HFD, indicating a shared susceptibility to liver lipid accumulation despite divergent systemic outcomes. In females, steatosis was associated with reduced mitochondrial respiratory complex IV activity and transcriptional remodeling that favored lipid storage. Treatment with the dual GLP1/GIP receptor agonist tirzepatide ameliorated systemic metabolic dysfunction and hepatic steatosis in HFD-fed female Brca1+/- mice. These findings identify Brca1 heterozygosity as a modifier of metabolic disease risk, expanding BRCA1 biology beyond tumor suppression. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=87 SRC="FIGDIR/small/708005v1_ufig1.gif" ALT="Figure 1"> View larger version (19K): org.highwire.dtl.DTLVardef@17f9592org.highwire.dtl.DTLVardef@134c2c2org.highwire.dtl.DTLVardef@de69d8org.highwire.dtl.DTLVardef@1f6f1af_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 10th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Obesity promotes breast epithelium DNA damage in BRCA mutation carriers
P. Bhardwaj, N. M. Iyengar, … K. A. Brown·bioRxiv·Jul 29, 2022
- Akr1d1-/- mice have a sexually dimorphic metabolic phenotype with reduced fat mass, increased insulin sensitivity and hypertriglyceridemia in males
L. L. Gathercole, N. Nikolaou, … J. W. Tomlinson·bioRxiv·Feb 2, 2021
- Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
S. Ali Mondal, S. Mann, … M. Stout·bioRxiv·Mar 25, 2023
- Loss of CTRP10 results in female obesity with preserved metabolic health
F. Chen, D. C. Sarver, … G. W. Wong·bioRxiv·Nov 1, 2023
- FABP7 Progenitors are a Targetable Metabolic Root in the BRCA1 Breast
C. W. McCloskey, B. Zhang, … R. Khokha·bioRxiv·Nov 2, 2023
- Estrogen Receptor Beta Activation Coordinates Liver Lipid Remodeling and Metabolic Fluxes, Preventing Lipotoxicity
Débora Santos Rocha, Eloisa Aparecida Vilas‐Boas, … Alicia Juliana Kowaltowski·Comprehensive physiologyPeer-reviewed·Jul 19, 2026